Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07164664Completed
Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Ondokuz Mayıs University. Primary endpoint: Cumulative opioid consumption in the first 24 hours after surgery. Started Sep 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07164664.